New breast cancer subtype responds to drug
ST. LOUIS, March 3 (UPI) — U.S. cancer experts say they’ve found a newly identified cancer biomarker might define a new subtype of breast cancer and offer a potential way to treat it.
Read more on UPI
New breast cancer subtype responds to drug
Most Still Not Getting Screened For Skin Cancer
Most Still Not Getting Screened For Skin Cancer
Despite all of the constant warnings about the dangers of sun exposure, skin cancer cases continue to rise with more than 3.5 million new cases diagnosed every year.
Read more on WBZ Boston
Related posts
FDA Approved Leukemia Drugs Shows Promise In Ovarian Cancer Cells
The drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian cancer in cell lines in which signaling of the Src family kinases, associated with the deadly disease, is activated.
The study appears in the Nov. 10, 2009 edition of the British Medical Journal.
Ovarian cancer, which will strike 21,600 women this year and kill 15,500, causes more deaths than any other cancer of the female reproductive system. Few effective therapies for ovarian cancer exist, so it would be advantageous for patients if a new drug could be found that fights the cancer, said Gottfried Konecny, an assistant professor of hematology/oncology, a Jonsson Cancer Center researcher and first author of the study.
» Read more: FDA Approved Leukemia Drugs Shows Promise In Ovarian Cancer Cells